Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IS3706Aexternal-prioritypatent/IS3706A7/en
Priority claimed from DK18392Aexternal-prioritypatent/DK18392D0/en
Application filed by IndividualfiledCriticalIndividual
Publication of CA2062094A1publicationCriticalpatent/CA2062094A1/en
Application grantedgrantedCritical
Publication of CA2062094CpublicationCriticalpatent/CA2062094C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Mania is treated by administering, to a patient in need thereof, galanthamine or a salt or derivative thereof or a functional equivalent of galanthamine, the functional equivalent being an acetylcholinesterase inhibitor which is active substantially selectively at nicotinic receptor sites.
CA 20620941991-05-141992-02-28Method of treating mania
Expired - Fee RelatedCA2062094C
(en)